Recent Developments of p38 MAP Kinase Inhibitors as Antiinflammatory Agents Based on the Imidazole Scaffolds

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|20|15|1997-2016

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.20, Iss.15, 2013-05, pp. : 1997-2016

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-05 ,pp. : 655-676

Bentham Science Publishers

Access to resources Recommend Favorite

Insight into the Structural Determinants of Imidazole Scaffold-Based Derivatives as P38 MAP Kinase Inhibitors by Computational Explorations

By  

Current Medicinal Chemistry, Vol. 19, Iss. 23, 2012-08 ,pp. : 4024-4037

Bentham Science Publishers

Access to resources Recommend Favorite

P38 MAP Kinase Inhibitors: Evolution of Imidazole-Based and Pyrido- Pyrimidin-2-One Lead Classes

By  

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 10, 2005-09 ,pp. : 987-1003

Bentham Science Publishers

Access to resources Recommend Favorite

Pyridinylimidazole Based p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 9, 2002-09 ,pp. : 1011-1020

Bentham Science Publishers

Access to resources Recommend Favorite

p38 MAP Kinase Inhibitors as Anti inflammatory Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 2082-2096

Bentham Science Publishers

Access to resources Recommend Favorite